review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JACI.2016.05.011 |
P698 | PubMed publication ID | 27373322 |
P50 | author | Peter J. Barnes | Q7174846 |
P2093 | author name string | Peter J Barnes | |
P2860 | cites work | Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1 | Q36889964 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
inflammation | Q101991 | ||
P304 | page(s) | 16-27 | |
P577 | publication date | 2016-05-27 | |
P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
P1476 | title | Inflammatory mechanisms in patients with chronic obstructive pulmonary disease | |
P478 | volume | 138 |
Q34558199 | A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation. |
Q92263764 | Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension |
Q54970130 | Airway Epithelium Dysfunction in Cystic Fibrosis and COPD. |
Q90091260 | Airway Resistance Caused by Sphingomyelin Synthase 2 Insufficiency in Response to Cigarette Smoke |
Q59806270 | Airway epithelial cells exposed to wildfire smoke extract exhibit dysregulated autophagy and barrier dysfunction consistent with COPD |
Q98177065 | Alteration of immunophenotype of human macrophages and monocytes after exposure to cigarette smoke |
Q58585945 | Alternative Oxidase Attenuates Cigarette Smoke-Induced Lung Dysfunction and Tissue Damage |
Q91828468 | Ambient particulate matter attenuates Sirtuin1 and augments SREBP1-PIR axis to induce human pulmonary fibroblast inflammation: molecular mechanism of microenvironment associated with COPD |
Q92218965 | Analysis of the level of selected parameters of inflammation, circulating immune complexes, and related indicators (neutrophil/lymphocyte, platelet/lymphocyte, CRP/CIC) in patients with obstructive diseases |
Q46248584 | Angiotensin-converting enzyme defines matrikine-regulated inflammation and fibrosis. |
Q77790108 | Association of occupational exposure to disinfectants with incidence of chronic obstructive pulmonary disease among US female nurses |
Q39071592 | Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function |
Q42354703 | Augmenting autophagy for prognosis based intervention of COPD-pathophysiology |
Q98735495 | B-Cell Activating Factor Secreted by Neutrophils Is a Critical Player in Lung Inflammation to Cigarette Smoke Exposure |
Q58580329 | Baicalin Exerts Anti-Airway Inflammation and Anti-Remodelling Effects in Severe Stage Rat Model of Chronic Obstructive Pulmonary Disease |
Q64929001 | Basophils trigger emphysema development in a murine model of COPD through IL-4-mediated generation of MMP-12-producing macrophages. |
Q92703279 | Blockade of EGFR Activation Promotes TNF-Induced Lung Epithelial Cell Apoptosis and Pulmonary Injury |
Q50046297 | Blood eosinophils as biomarkers to drive treatment choices in asthma and COPD. |
Q93388171 | Bronchoalveolar pH and inflammatory biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease |
Q47822950 | Characteristic plethysmographic findings in a guinea pig model of COPD. |
Q49733315 | Cigarette Smoke Exposure Inhibits Bacterial Killing via TFEB-Mediated Autophagy Impairment and Resulting Phagocytosis Defect |
Q44591933 | Cigarette smoke promotes COPD by activating platelet-activating factor receptor and inducing neutrophil autophagic death in mice. |
Q92000082 | Cigarette smoking induces human CCR6+Th17 lymphocytes senescence and VEGF-A secretion |
Q97537457 | Circulating miRNAs as molecular markers of occupational grain dust exposure |
Q89735521 | Clinical And Economic Burden Of Eosinophilic COPD In A Large Retrospective US Cohort |
Q97537445 | Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational study |
Q92149664 | Clinical significance of BPI-ANCA detecting in COPD patients with Pseudomonas aeruginosa colonization |
Q55387022 | Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients. |
Q55428223 | Coronary lesions in patients with COPD (Global Initiative for Obstructive Lung Disease stages I–III) and suspected or confirmed coronary arterial disease. |
Q59813607 | Correlation of serum levels of HIF-1α and IL-19 with the disease progression of COPD: a retrospective study |
Q52562729 | Critical regulation of inflammation via class A scavenger receptor. |
Q52327746 | Crocin attenuates cigarette smoke-induced lung injury and cardiac dysfunction by anti-oxidative effects: the role of Nrf2 antioxidant system in preventing oxidative stress. |
Q52726339 | Defective formyl peptide receptor 2/3 and annexin A1 expressions associated with M2a polarization of blood immune cells in patients with chronic obstructive pulmonary disease. |
Q47133214 | Deficiency of innate-like T lymphocytes in chronic obstructive pulmonary disease |
Q99583662 | Dissociation between airway and systemic autoantibody responses in chronic obstructive pulmonary disease |
Q90461041 | Dysregulation of the Tryptophan Pathway Evidences Gender Differences in COPD |
Q91788890 | Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial |
Q93358549 | Effect of Syringic acid on antioxidant biomarkers and associated inflammatory markers in mice model of asthma |
Q38621352 | Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis |
Q96306099 | Effects of conjugated linoleic acid supplementation on serum levels of interleukin-6 and sirtuin 1 in COPD patients |
Q37553291 | Elastase-Induced Parenchymal Disruption and Airway Hyper Responsiveness in Mouse Precision Cut Lung Slices: Toward an Ex vivo COPD Model |
Q96222995 | Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema |
Q61727843 | Eosinophil-derived IL-13 Promotes Emphysema |
Q64259861 | Epigenetic impacts of maternal tobacco and e-vapour exposure on the offspring lung |
Q98772259 | Epithelial cell-specific loss of function of Miz1 causes a spontaneous COPD-like phenotype and up-regulates Ace2 expression in mice |
Q91827939 | Erythromycin Prevents Elastin Peptide-Induced Emphysema and Modulates CD4+T Cell Responses in Mice |
Q64062027 | Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts |
Q37671430 | Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation. |
Q47658841 | Exercise Inhibits the Effects of Smoke-Induced COPD Involving Modulation of STAT3. |
Q64954755 | Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. |
Q92002839 | FGF2, an Immunomodulatory Factor in Asthma and Chronic Obstructive Pulmonary Disease (COPD) |
Q90699927 | Fruit and Vegetable Intake and the Risk of Chronic Obstructive Pulmonary Disease: A Dose-Response Meta-Analysis of Observational Studies |
Q55070093 | Function of macrophage scavenger receptor 1 gene polymorphisms in chronic obstructive pulmonary disease with and without lung cancer in China. |
Q55981706 | GOLD 2017 recommendations for COPD patients: toward a more personalized approach |
Q94588294 | GTS-21, an α7nAChR agonist, suppressed the production of key inflammatory mediators by PBMCs that are elevated in COPD patients and associated with impaired lung function |
Q90121622 | Gallic acid protects against the COPD-linked lung inflammation and emphysema in mice |
Q37721580 | HDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice |
Q40097568 | Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways |
Q90701361 | Hydrogen gas inhalation protects against cigarette smoke-induced COPD development in mice |
Q89905396 | Hyperuricemia Is Not Predictive of Long-Term Outcome in Patients with Stable Chronic Obstructive Pulmonary Disease |
Q40269947 | IFN Regulatory Factor 3 Potentiates Emphysematous Aggravation by Lipopolysaccharide |
Q37637477 | IL-10-Producing CD1dhiCD5+ Regulatory B Cells May Play a Critical Role in Modulating Immune Homeostasis in Silicosis Patients |
Q91968542 | IL-17C-mediated innate inflammation decreases the response to PD-1 blockade in a model of Kras-driven lung cancer |
Q64951975 | IL-33 induces production of autoantibody against autologous respiratory epithelial cells: a potential mechanism for the pathogenesis of COPD. |
Q90322419 | IL10 deficiency promotes alveolar enlargement and lymphoid dysmorphogenesis in the aged murine lung |
Q49284188 | Immune cell response to strenuous resistive breathing: comparison with whole body exercise and the effects of antioxidants |
Q38977628 | Immune-mediated inflammation in the pathogenesis of emphysema: insights from mouse models |
Q38848702 | Impact of chronic kidney disease among Korean adults with chronic obstructive pulmonary disease |
Q60921087 | In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients |
Q33812986 | Inactivation of the Thymidylate Synthase thyA in Non-typeable Haemophilus influenzae Modulates Antibiotic Resistance and Has a Strong Impact on Its Interplay with the Host Airways. |
Q41042662 | Increased Levels of Pro-Inflammatory and Anti-Inflammatory Cellular Responses in Parkinson's Disease Patients: Search for a Disease Indicator. |
Q54114455 | Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline. |
Q91767893 | Independent factors associate with hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease requiring intensive care unit admission: Focusing on the eosinophil-to-neutrophil ratio |
Q53697380 | Inflammatory and Metabolic Responses to Different Resistance Training on Chronic Obstructive Pulmonary Disease: A Randomized Control Trial. |
Q64966018 | Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases. |
Q89882349 | Integrated transcriptomic correlation network analysis identifies COPD molecular determinants |
Q89907088 | Interleukin-17A Deficiency Attenuated Emphysema and Bone Loss in Mice Exposed to Cigarette Smoke |
Q64949368 | Is atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers? |
Q90396582 | Jian-Pi-Yi-Fei granule suppresses airway inflammation in mice induced by cigarette smoke condensate and lipopolysaccharide |
Q92993366 | Loss of skin elasticity is associated with pulmonary emphysema, biomarkers of inflammation, and matrix metalloproteinase activity in smokers |
Q61447292 | Loss of the adhesion G-protein coupled receptor ADGRF5 in mice induces airway inflammation and the expression of CCL2 in lung endothelial cells |
Q89510732 | Lung Macrophage Functional Properties in Chronic Obstructive Pulmonary Disease |
Q49805694 | Lung Macrophage Phenotypes and Functional Responses: Role in the Pathogenesis of COPD. |
Q59813703 | Lung Protection Strategies during Cardiopulmonary Bypass Affect the Composition of Blood Electrolytes and Metabolites-A Randomized Controlled Trial |
Q55361477 | Lung cellular senescence is independent of aging in a mouse model of COPD/emphysema. |
Q64910929 | Macrophage function in chronic obstructive pulmonary disease: The many faces of notch signalling. |
Q102054047 | Macrophage metabolic reprogramming during chronic lung disease |
Q92352889 | Macrophages exposed to HIV viral protein disrupt lung epithelial cell integrity and mitochondrial bioenergetics via exosomal microRNA shuttling |
Q97521557 | Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation |
Q55517666 | Microbial and host immune factors as drivers of COPD. |
Q49729993 | Mitochondrial DNA damage and subsequent activation of Z-DNA binding protein 1 links oxidative stress to inflammation in epithelial cells |
Q55347367 | Modulation of Haemophilus influenzae interaction with hydrophobic molecules by the VacJ/MlaA lipoprotein impacts strongly on its interplay with the airways. |
Q93126824 | Molecular Characteristics and Treatment of Endothelial Dysfunction in Patients with COPD: A Review Article |
Q38989502 | Molecular targets of developmental exposure to bisphenol A in diabesity: a focus on endoderm-derived organs. |
Q38747579 | Morning symptoms in COPD: a treatable yet often overlooked factor. |
Q97643629 | NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD |
Q64118155 | New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease |
Q92441059 | Office-Based Sedation/General Anesthesia for COPD Patients, Part II |
Q46165199 | Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease |
Q96953110 | Paraoxonase Activity and Phenotype Distribution in Patients with Chronic Obstructive Pulmonary Disease |
Q49865249 | Pathogenic TH17 inflammation is sustained in the lungs by conventional dendritic cells and Toll-like receptor 4 signaling |
Q92798698 | Peripheral blood CD4+ T cell populations by CD25 and Foxp3 expression as a potential biomarker: reflecting inflammatory activity in chronic obstructive pulmonary disease |
Q53440054 | Physiopathological relationship between chronic obstructive pulmonary disease and insulin resistance. |
Q91992623 | Platelet indices in stable chronic obstructive pulmonary disease - association with inflammatory markers, comorbidities and therapy |
Q58804231 | Precision medicine in COPD: where are we and where do we need to go? |
Q90423097 | Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies |
Q59126531 | Predictive value of neutrophil to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease |
Q58584106 | Protective Effects of Anti-IL17 on Acute Lung Injury Induced by LPS in Mice |
Q33603530 | Pulmonary Extracellular Vesicles as Mediators of Local and Systemic Inflammation |
Q64086915 | RNA-sequencing across three matched tissues reveals shared and tissue-specific gene expression and pathway signatures of COPD |
Q64898412 | Recombinant club cell protein 16 (CC16) ameliorates cigarette smoke‑induced lung inflammation in a murine disease model of COPD. |
Q42359679 | Recuperating lung decoction attenuates inflammation and oxidation in cigarette smoke-induced COPD in rats via activation of ERK and Nrf2 pathways. |
Q89717703 | Relationship between occupational dust exposure levels and mental health symptoms among Korean workers |
Q47563688 | Resveratrol for patients with chronic obstructive pulmonary disease: hype or hope? |
Q42379026 | Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae. |
Q55518899 | Ribosomal Protein S3 Gene Silencing Protects Against Cigarette Smoke-Induced Acute Lung Injury. |
Q47159702 | Role of the inflammasome in chronic obstructive pulmonary disease (COPD). |
Q38681962 | Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases |
Q57043148 | S100A8 Protects Human Primary Alveolar Type II Cells Against Injury and Emphysema |
Q54970037 | SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease. |
Q90754511 | Self-DNA release and STING-dependent sensing drives inflammation to cigarette smoke in mice |
Q41632970 | Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD |
Q92059873 | Serum β2-Microglobulin is Associated with Mortality in Hospitalized Patients with Exacerbated Chronic Obstructive Pulmonary Disease |
Q38776298 | Shifting from Correlation to Causation: Challenges for the Future of Unbiased Molecular Studies in Inflammatory Lung Disease. |
Q47664739 | Soluble guanylate cyclase stimulation reduces oxidative stress in experimental Chronic Obstructive Pulmonary Disease. |
Q90526178 | Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis |
Q90135430 | Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients |
Q89876173 | Systems biology analysis of publicly available transcriptomic data reveals a critical link between AKR1B10 gene expression, smoking and occurrence of lung cancer |
Q99614965 | Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease |
Q57712790 | Targeting transcription factor lysine acetylation in inflammatory airway diseases |
Q91632536 | The Bronchiectasis in COPD-OSA Overlap Syndrome Patients |
Q64905994 | The Notch ligand DNER regulates macrophage IFNγ release in chronic obstructive pulmonary disease. |
Q64236830 | The Role of Autophagy in Eosinophilic Airway Inflammation |
Q28077460 | The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect? |
Q59793529 | The association of elevated circulating endocan levels with lung function decline in COPD patients |
Q89688973 | The bidirectional relationship between chronic obstructive pulmonary disease and coronary artery disease |
Q90242330 | The effects of BAFF on T lymphocytes in chronic obstructive pulmonary disease |
Q48193738 | The long pentraxin PTX3: A prototypical sensor of tissue injury and a regulator of homeostasis |
Q91132654 | The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress |
Q38972632 | Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach |
Q90353265 | Therapeutic potential of BLT1 antagonist for COPD: involvement of inducing autophagy and ameliorating inflammation |
Q92656923 | Therapeutic suppression of pulmonary neutrophilia and allergic airway hyperresponsiveness by a RORγt inverse agonist |
Q64102606 | Transient Receptor Potential Melastatin 8 (TRPM8)-Based Mechanisms Underlie Both the Cold Temperature-Induced Inflammatory Reactions and the Synergistic Effect of Cigarette Smoke in Human Bronchial Epithelial (16HBE) Cells |
Q64078726 | Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status |
Q51450105 | Understanding disease mechanisms at the nanoscale: endothelial apoptosis and microparticles in COPD. |
Q64084566 | Understanding the role of neutrophils in chronic inflammatory airway disease |
Q57873240 | Use of nonhuman primates in obstructive lung disease research – is it required? |
Q33703730 | Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine) |
Q58605680 | White blood cell count and all-cause and cause-specific mortality in the Guangzhou biobank cohort study |
Q92237314 | [Research Progress of Treg/Th17 in the Treatment of Chronic Obstructive Pulmonary Disease with Lung Cancer] |
Q92366057 | hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study |
Search more.